Clinical Trial Update: Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant paclitaxel and carboplatin in operable locally advanced head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Yonsei University | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN